Status:
COMPLETED
Randomized Comparison of xiEnce and visioN Coronary Stents in the sAme muLtivessel Patient With Chronic kiDnEy diSease
Lead Sponsor:
European Hospital
Conditions:
Chronic Kidney Disease
Multivessel Coronary Artery Disease
Eligibility:
All Genders
18-85 years
Phase:
PHASE2
Brief Summary
Percutaneous coronary intervention (PCI) with bare metal stent (BMS) in patients with renal insufficiency has shown unsatisfactory results. Indeed, drug-eluting stents (DES) might reduce the incidence...
Eligibility Criteria
Inclusion
- chronic renal insufficiency (creatinine clearance \<60 ml/min, in dialysis patients included) with at least two significant (\>70%) coronary lesions in two major coronary vessels.
Exclusion
- Age \>85 years
- left main coronary artery disease
- saphenous vein graft disease
- ST-elevation MI (\<3 days)
- coronary vessel diameter \<2.5 or \> 4 mm
- contraindication to long-term double antiplatelet therapy
- CABG indication by consensus (cardiovascular team)
- severe valvular heart disease
- informed consent not obtained
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2012
Estimated Enrollment :
215 Patients enrolled
Trial Details
Trial ID
NCT00818792
Start Date
January 1 2009
End Date
September 1 2012
Last Update
January 15 2013
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
European Hospital
Rome, Italy, 00149
2
Azienda Ospedaliera Istituti Ospitalieri di Verona
Verona, Italy, 37126